Jeannette Vasquez-Vivar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jeannette Vasquez-Vivar has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Jennifer Whitsett
Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA
6 shared publications- Pavel Martásek
First Faculty of Medicine, Charles University, Kateřinská 32, 121 08 Prague 2, Czech Republic
4 shared publications B. Kalyanaraman
Biophysics Research Institute and Free Radical Research Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA
3 shared publicationsBalaraman Kalyanaraman
Department of Biophysics, Medical College of Wisconsin, Milwaukee WI 53226, USA
2 shared publicationsSavitha Sethumadhavan
2 shared publicationsSidhartha Tan
Department of Pediatrics, Wayne University, Detroit, MI, 48201, USA
2 shared publications
Latest Publications
- Open Access
- 30 November 2024
- Published by Elsevier in Redox Biology
- Vol. 79, 103447
Tetrahydrobiopterin as a rheostat of cell resistance to oxidant injury
- 30 November 2024
- Published by Elsevier in Redox Biology
- Vol. 79, 103447
Open AccessTetrahydrobiopterin as a rheostat of cell resistance to oxidant injury
- 21 January 2020
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 152, 689-696
In vivo vascular rarefaction and hypertension induced by dexamethasone are related to phosphatase PTP1B activation not endothelial metabolic changes
- 21 January 2020
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 152, 689-696
In vivo vascular rarefaction and hypertension induced by dexamethasone are related to phosphatase PTP1B activation not endothelial metabolic changes
- Open Access
- 6 March 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (5) , 1143
Treatment of Cells and Tissues with Chromate Maximizes Mitochondrial 2Fe2S EPR Signals
In a previous study on chromate toxicity, an increase in the 2Fe2S electron paramagnetic resonance (EPR) signal from mitochondria was found upon addition of chromate to human bronchial epithelial cells and bovine airway tissue ex vivo. This study was undertaken to show that a chromate-induced increase in the 2Fe2S EPR signal is a general phenomenon that can be used as a low-temperature EPR method to determine the maximum concentration of 2Fe2S centers in mitochondria. First, the low-temperature EPR method to determine the concentration of 2Fe2S clusters in cells and tissues is fully developed for other cells and tissues. The EPR signal for the 2Fe2S clusters N1b in Complex I and/or S1 in Complex II and the 2Fe2S cluster in xanthine oxidoreductase in rat liver tissue do not change in intensity because these clusters are already reduced; however, the EPR signals for N2, the terminal cluster in Complex I, and N4, the cluster preceding the terminal cluster, decrease upon adding chromate. More surprising to us, the EPR signals for N3, the cluster preceding the 2Fe2S cluster in Complex I, also decrease upon adding chromate. Moreover, this method is used to obtain the concentration of the 2Fe2S clusters in white blood cells where the 2Fe2S signal is mostly oxidized before treatment with chromate and becomes reduced and EPR detectable after treatment with chromate. The increase of the g = 1.94 2Fe2S EPR signal upon the addition of chromate can thus be used to obtain the relative steady-state concentration of the 2Fe2S clusters and steady-state concentration of Complex I and/or Complex II in mitochondria.
- 6 March 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (5) , 1143
Open AccessTreatment of Cells and Tissues with Chromate Maximizes Mitochondrial 2Fe2S EPR Signals
In a previous study on chromate toxicity, an increase in the 2Fe2S electron paramagnetic resonance (EPR) signal from mitochondria was found upon addition of chromate to human bronchial epithelial cells and bovine airway tissue ex vivo. This study was undertaken to show that a chromate-induced increase in the 2Fe2S EPR signal is a general phenomenon that can be used as a low-temperature EPR method to determine the maximum concentration of 2Fe2S centers in mitochondria. First, the low-temperature EPR method to determine the concentration of 2Fe2S clusters in cells and tissues is fully developed for other cells and tissues. The EPR signal for the 2Fe2S clusters N1b in Complex I and/or S1 in Complex II and the 2Fe2S cluster in xanthine oxidoreductase in rat liver tissue do not change in intensity because these clusters are already reduced; however, the EPR signals for N2, the terminal cluster in Complex I, and N4, the cluster preceding the terminal cluster, decrease upon adding chromate. More surprising to us, the EPR signals for N3, the cluster preceding the 2Fe2S cluster in Complex I, also decrease upon adding chromate. Moreover, this method is used to obtain the concentration of the 2Fe2S clusters in white blood cells where the 2Fe2S signal is mostly oxidized before treatment with chromate and becomes reduced and EPR detectable after treatment with chromate. The increase of the g = 1.94 2Fe2S EPR signal upon the addition of chromate can thus be used to obtain the relative steady-state concentration of the 2Fe2S clusters and steady-state concentration of Complex I and/or Complex II in mitochondria.
- Open Access
- 1 October 2017
- Published by Elsevier in Redox Biology
- Vol. 13, 594-599
Tetrahydrobiopterin in antenatal brain hypoxia-ischemia-induced motor impairments and cerebral palsy
- 1 October 2017
- Published by Elsevier in Redox Biology
- Vol. 13, 594-599
Open AccessTetrahydrobiopterin in antenatal brain hypoxia-ischemia-induced motor impairments and cerebral palsy
- 1 July 2016
- Published by Elsevier in Pregnancy Hypertension
- Vol. 6 (3) , 156
40 Sepiapterin, a potential therapeutic approach to restore the metabolic phenotype switch induced by sFlt-1 in preeclampsia
- 1 July 2016
- Published by Elsevier in Pregnancy Hypertension
- Vol. 6 (3) , 156
40 Sepiapterin, a potential therapeutic approach to restore the metabolic phenotype switch induced by sFlt-1 in preeclampsia
- 1 November 2014
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 76, S54-S55
Tetrahydrobiopterin Inhibits Uncoupled Superoxide from Glutathionylated-eNOS
- 1 November 2014
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 76, S54-S55
Tetrahydrobiopterin Inhibits Uncoupled Superoxide from Glutathionylated-eNOS
- 1 February 2014
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 67, 426-436
Developmental susceptibility of neurons to transient tetrahydrobiopterin insufficiency and antenatal hypoxia–ischemia in fetal rabbits
- 1 February 2014
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 67, 426-436
Developmental susceptibility of neurons to transient tetrahydrobiopterin insufficiency and antenatal hypoxia–ischemia in fetal rabbits
- Open Access
- 1 October 2013
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 63, 143-150
Human endothelial dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recycling
- 1 October 2013
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 63, 143-150
Open AccessHuman endothelial dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recycling
- Open Access
- 1 June 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (26) , 22174-22182
Mitochondrial DNA Variant for Complex I Reveals a Role in Diabetic Cardiac Remodeling
- 1 June 2012
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (26) , 22174-22182
Open AccessMitochondrial DNA Variant for Complex I Reveals a Role in Diabetic Cardiac Remodeling
- 31 December 2010
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 49, S32
Role of Dihydrofolate Reductase in Atherosclerosis
- 31 December 2010
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 49, S32
Role of Dihydrofolate Reductase in Atherosclerosis